A Genome-wide Linkage Analysis and Mutation Analysis of Hereditary Congenital Blepharoptosis in a Japanese Family by Nakashima Mitsuko et al.
- 1 -M. Nakashima et al. 
A Genome-wide Linkage Analysis and Mutation Analysis of Hereditary Congenital 
Blepharoptosis in a Japanese Family 
 
Mitsuko Nakashima1,2, Motoi Nakano2, Akiyoshi Hirano2, Tatsuya Kishino3,5, Shinji 
Kondoh3,5, Nobutomo Miwa1,5, Norio Niikawa4,5, Koh-ichiro Yoshiura1,5 
 
1Department of Human Genetics and 2Division of Plastic and Reconstructive Surgery, 
Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; 3Division 
of Functional Genomics, Center for Frontier Life Sciences, Nagasaki University, Nagasaki, 
Japan; 4The Research Institute of Personalized Health Sciences, Health Sciences University 
of Hokkaido, Hokkaido, Japan; 5Solution Oriented Research for Science and Technology 





Correspondence to Dr. Koh-ichiro Yoshiura, Department of Human Genetics, Nagasaki 
University Graduate School of Biomedical Sciences, Sakamoto 1-12-4, Nagasaki 852-8523, 
Japan. 
TEL: +81-95-849-7120; FAX: +81-95-849-7121; e-mail: kyoshi@nagasaki-u.ac.jp
 1
- 2 -M. Nakashima et al. 
 2
              ABSTRACT 
Hereditary congenital ptosis (PTOS) is defined as drooping of the upper eyelid without 
any other accompanying symptoms and distinguished from syndromic blepharoptosis.  
Two previous linkage analyses assigned a PTOS locus (PTOS1) to 1p32-p34.1 and another 
(PTOS2) to Xq24-q27.1.  In addition, in a sporadic case with a balanced chromosomal 
translocation t(1;8)(p34.3;q21.12), the ZFHX4 (zinc finger homeodomain 4) gene was 
found to be disrupted at the 8q21.12 breakpoint, but there was no gene at the 1p34.3 
breakpoint, suggesting the existence of the third PTOS locus (PTOS1) at 8q21.12.  We 
carried out a genome-wide linkage analysis in a Japanese PTOS family and calculated 
two-point and multipoint LOD scores with reduced penetrance.  Haplotype analysis gave 
three candidate disease-responsible regions, i.e., 8q21.11-q22.1, 12q24.32-q24.33 and 
14q21.1-q23.2.  Although the family size is too small to define one of them, 
8q21.11-q22.1 is a likely candidate region, because it contains the previously reported 
translocation breakpoint above.  We thus performed mutation, Southern-blot and 
methylation analyses of ZFHX4, but could not find any disease specific change in the 
family.  Nevertheless, our data may support the localization of PTOS1.  
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INTRODUCTION 
Blepharoptosis is pathological drooping of the upper eyelid.  It is classified into 
myogenic, neurogenic, aponeurotic and mechanical ptosis, according to the primarily 
affected lesion.  Hereditary congenital ptosis (PTOS) distinguished from other syndromic 
blepharoptosis involves only the upper eyelid.  PTOS is genetically heterogeneous and 
two modes of inheritance have been known: autosomal dominant PTOS1 (MIM %178300) 
and X-linked PTOS2 (MIM %300245).  Autosomal PTOS may be further devided into at 
least two types.  Engle et al. (1997) mapped PTOS1 by linkage analysis to 1p32-p34.1, 
while McMullan et al. (2002) found, by the analysis of a sporadic case of PTOS who had a 
de novo balanced chromosomal translocation t(1;8)(p34.3;q21.12), that the ZFHX4 gene at 
8q21.12 was disrupted by the translocation but there was no gene at the 1p34.3 breakpoint, 
suggesting the third locus at 8q21.12.  
We recently encountered a Japanese family with PTOS in which there are nine affected 
members in five successive generations.  Here we report on a linkage analysis and 
mutation analysis of a candidate gene, ZFHX4.   
 
MATERIALS AND METHODS 
Family and Patients 
A Japanese family consisted of at least nine members affected with PTOS in five 
generations (Fig. 1).  The disease in the family was found in both sexes and transmitted 
(male to male transmissions twice) directly through successive generations, indicatng that it 
is autosomal dominant PTOS.  A total of 18 members including five affected and 12 
non-affected members, and one of their spouses participated in this study.  The proposita 
(V-5, Figs. 1 and 2) suffered from congenital ptosis on her right eye, and visited Department 
of Plastic and Reconstructive Surgery, Nagasaki University Hospital at age 15 years.  She 
had severe ptosis (drooping > 4 mm, levator function = 5 mm) without any other 
ophthalmic disorders and appeared to have overaction of the frontalis muscle.  She had 
undergone a levator muscle shortening surgery for her ptosis.  Three patients (III-13, IV-2 
and IV-12) suffered from unilateral congenital ptosis and all had undergone a repair surgery.  
The other patient (III-5) with bilateral ptosis has received no surgical treatment.  None of 
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the five patients had any associated ophthalmic disorders and all were examined by one or 
two well-trained plastic surgeons.  The study protocol was approved by the Committee for 
the Ethical Issues on Human Genome and Gene Analysis in Nagasaki University. 
 
Linkage and Haplotype Analyses 
After obtaining written informed consent from each participant, DNA was extracted by 
conventional method from their whole blood, or using ISOHAIRTM (Nippon Gene, Tokyo, 
Japan) from their fingernail clippings, concentrated, and then purified by 
phenol-chloroform method (Matsuzawa et al. 2006)  For whole-genome scanning, we 
used ABI Prism Linkage Mapping Set-MD10 (AppliedBiosystems, Foster City, CA, USA) 
that consists of 386 microsatellite markers from whole chromosomes with average distance 
of about 10 cM.  Polymerase chain reaction (PCR) was performed in a 10 μl mixture 
containing 5 ng genomic DNA/0.25 U ExTaq DNA polymerase HS-version (TAKARA Bio 
Inc., Kyoto, Japan)/200 μM dNTP/0.3 μM primer/1xPCR buffer on the Dual 384-well 
GeneAmp PCR System 9700 Thermal Cycler (AppliedBiosystems).  The PCR condition 
was composed of initial denaturation at 94 °C for 3 min, followed by 37 (blood samples) or 
44 (nail samples) cycles of amplification at 94 °C, 30 sec/55 °C, 30 sec/72 °C, 30 sec, and 
final extension at 72 °C for 7 min.  PCR products were analysed on an Autosequencer 
Model 3100. Genotyping was carried out using GeneScan and Genotyper software 
(AppliedBiosystems).   
Two-point LOD score was calculated using MLINK program (included in FASTLINK 
software version 4.0P) (Lathrop et al. 1984), and multipoint LOD score and nonparametric 
LOD score were calculated using Genehunter software (Kruglyak et al. 1996).  To pick up 
all possibly linked loci, calculation was based on an assumption that the ptosis in the family 
is an autosomal dominant trait with 90% penetrance (p=0.9) and on the allele frequency of 
1/N, where the number of alleles is N.  Haplotypes around loci with positive LOD scores 
were constructed with 4 or 5 microsatellite markers that were set up at intervals of 2-3 cM.  
Information of these microsatellite markers was referred to the NCBI database (Map 
Viewer: Marshfield and/or decode map). 
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Mutation Analysis 
 ZFHX4 reported to have been disrupted by a translocation in a patient with PTOS 
(McMullan et al. 2002) is located at 8q21.1.  As its chromosomal localization is one of 
candidate regions we identified in the present study, we performed direct sequencing of all 
exons of ZFHX4 using DNA from one affected member (III-5) and one unaffected member 
(IV-1) in the family.  The genomic sequence of ZFHX4 was retrieved from the UCSC 
Genome Browser Home (http://genome.ucsc.edu/) and from the Ensemble Genome 
Browser (http://ensembl.org/index.html).  Primers were designed from sequences of each 
exon and those around respective intron. PCR was performed in a 15 μl reaction mixture 
containing 5 ng DNA/0.4 U ExTaq DNA polymerase/200 μM dNTP/0.67 μM each 
primer/1xPCR buffer on DNA Thermal Cycler Model 9700 (AppliedBiosystems) with a 
condition of initial denaturation at 94 °C for 3 min, amplification for 37 cycles at 94 °C, 
30sec/60 °C, 30 sec/72 °C, 30-60 sec, and final extension at 72 °C for 7 min.  PCR 
products were subjected to cleaning-up using Exonuclease I (Epicentre, WI, USA) and 
shrimp alkaline phosphatase (AmershamBioscience, NJ, USA) for direct sequence reaction.  
Direct sequencing was carried out using BigDye-terminator sequencing reagent version-3.1 
(AppliedBiosystems) on an Autosequencer Model 3100, and sequences were aligned with 
ATGC software (GENETYX Corp., Tokyo, Japan). 
 
Southern Blot Analysis 
Genomic DNA from a patient (III-5) as a representative from the family was digested 
with three different enzymes (BamHI, EcoRI, HindIII) and electrophoresed on 0.8% 
agarose gel in 0.5xTBE buffer containing 0.25 μg/ml ethidium bromide at 35~40 volts for 
6-10 hrs.  DNA was then denatured with 0.4 N NaOH for 15-20 min and 
capillary-transferred overnight onto nylon membrane (HybondN+, AmershamPharmacia 
Biotech, Buckinghamshire, UK) using alkaline transfer buffer, and the membrane was 
washed twice with 2xSSC.  DNA fixed to the membrane by UV cross-linking was 
hybridized to fluorescein-labeled probes using Gene Images Random Prime Labeling Kit 
(AmershamBiosciences).  Hybridized signal was detected using Gene Image CDP-Star 
Detection Kit (AmershamBiosciences).  Genomic DNA from phenotypically normal 
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individuals were used as controls. 
  
Methylation Analysis of ZFHX4 
DNA (1 μg) from patients and a control individual was modified with sodium bisulfite 
using CpGenome DNA modification Kit (CHEMICON, CA, USA).  PCR primers 
specific for methylated or unmethylated DNA (Herman et al. 1996) were desinged from 
sequences of two CpG islands of ZFHX4 (Table 1) at which one island is located 3-kb 
upstream and the other 0.4-kb downstream of exon 1, espectively (Hemmi et al. 2006).  
Methylation-specific PCR was performed in a 20 μl reaction mixture containing 50 ng 
bisulfite-modified DNA/0.5 U AmpliTaq Gold (AppliedBiosystems)/200 μM dNTP/0.5 
μM each primer/1xPCR buffer with a condition consisting of initial denaturation at 95 °C 
for 10 min, 37 cycles of amiplification at 94 °C, 30 sec/60 °C, 30 sec/72 °C, 30 sec, and 
final extension at 72 °C for 10 min.  PCR products were analyzed by electrophoresis on 
2.5% agarose gel.  Because aberrant signals on Southern blot were observed, the 
bisulfite-modified DNA was also amplified with specific primers for EcoRI site around 
exon12 of ZFHX4.  PCR products were cloned using TOPO TA cloning Kit (Invitrogen, 
Carlsbad, CA, USA), and then cloned DNA was sequenced (Clark et al. 1994).  
 
RESULTS 
Linkage and Haplotype Analyses 
As the number of affected members in this family was small and penetrance might be 
considerably low, we set a cut-off LOD score ≥ 0.4 in all calculations.  The two-point and 
multi-point analyses gave nine markers (D1S255, D1S484, D5S630, D7S669, D9S1776, 
D11S4046, D19S221, D19S226, and D14S276) that show such scores, and the 
non-prametric analysis gave four candidate regions (3q22.1, 8q21.11, 12q24.32, and 20p13).  
The haplotype analysis at these loci revealed that all but 8q21.1, 12q24.3 and 14q22.3 
regions (Fig. 1) were excluded, because some patients do not have putative disease-linked 
haplotypes (data not shown).  Thus, we finally left these three regions commonly shared 
by the patients as candidates.  Further refinement was impossible, because any more 
family samples were not available.  
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Mutation Analysis of the ZFHX4 Gene 
The direct sequencing of ZFHX4 revealed one missense alteration (G12411T or 
L4137F) in exon12 in the affected member and some normal control samples (data not 
shown), indicating that it is actually a single nucleotide polymorphism (SNP).  Likewise, 
another mutation analysis for homologous sequences between the mouse and human in 
their promotor/enhancer region of ZFHX4/Zfhx4 revealed no disease-associated mutation in 
the patient.  Southern blot analysis using a probe for exon 2 or exon 12 of ZFHX4 detected 
an respective extra EcoRI-fragment in a patient (III-5) (Fig. 3), and an extra band for exon 
12 also in two other patients (III-13 and IV-12), while there were no aberrant signals with 
other restriction enzymes.  However, sequence analysis of these regions did not identify 
any genomic rearrangements, and confirmed no RFLP around exon 2 or 12. These led us to 
try to detect the differential methylation status in the regions between patients and normal 
controls.  However, methylation-specific PCR following a bisulfite treatment revealed no 
change of the methylation status in the patient’s two CpG-islands (data not shown). 
 
DISCUSSION 
In this study, we performed linkage and haplotype analyses of a Japanese PTOS 
pedigree.  Consequently, three regions, 8q21.11-q22.2, 12q24.32-qter and 14q21.1-q23.2, 
were shown to be candidates.  The two-point maximum LOD scores were considerably 
low, being 1.16, 0.47 and 0.72 at D8S551, D12S1659 and D14S276 (Table 2), respectively, 
because some unaffected family members also had disease-linked haplotypes around the 
markers.  It was obvious that the disease in the family shows incomplete penetrance.  
Although we diagnosed carefully many members of the family at the beginning of this 
study, we might have overlooked very mildly affected members.   
Two regions responsible for autosomal PTOS were reported previously, i.e., 1p34.1-p32 
for PTOS1 by linkage analysis (Engle et al. 1997) and 1p34.3/8q21.12 by analysis of a 
chromosomal translocation (McMullan et al. 2002).  Three candidate loci we have 
detected include the translocation breakpoint, 8q21.2 (McMullan et al. 2002), but do not 
contain 1p34.1-p32 (Engle et al. 1997).  Therefore, the disease locus for our family could 
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be associated with PTOS1.  However, we failed to identify in our family any point 
mutation, genomic rearrangement or methylation aberration involving ZFHX4 that was 
disrupted at the 8q21.12 breakpoint of the translocation in a PTOS patient (McMullan et al. 
2002). 
The human ZFHX4 gene spans about 180-kb long, contains 12 exons, is mapped at 
8q13.3-q21.11, and has >90% homology to the mouse Zfh4 and 52% to the human ATBF1 
(Hemmi et al. 2006).  The Zfh4 gene encodes a member of the zincfinger-homeodomain 
family which has 4 homeodomains and 22 zinc fingers (Sakata et al. 2000).  Zfh4 was 
highly expressed in developing muscle and brains of the mouse, especially in the midbrain 
and hindbrain (Kostich and Sanes 1995), and was also detected in adult rat oculomotor 
nucleus which controls the levator palpebrae superioris (LPS) muscle (Nogami et al. 2005).  
The oculomotor nucleus exists in the mesencephalon.  The oculomotor nerve innervates to 
LPS and the extraocular muscles except for the lateral rectus and the superior oblique 
muscle, and also supplies parasympathetic preganglionic fibers to the ciliary ganglion 
through which postganglionic nerve controls the ciliary muscle and the sphincter muscle of 
pupil.  It was reported that ZFHX4 was upregulated in postmitotic neurons and suggested 
that ZFHX4 was influenced on neural differentiation including migration and axon 
out-growth (Nogami et al. 2005; Hemmi et al. 2006).  All these lines of evidence strongly 
suggest that ZFHX4 is the responsible gene for a type of PTOS.   
There are two opinions concerning the pathological change in LPS from congenital 
ptosis.  Three reports approved that congenital ptosis is caused by primary dysgenesis or 
myodystrophy of LPS (Berke and Wadsworth. 1955; Isaksson et al. 1961; 1962; Stula et al. 
1988).  On the other hand, Edmunds et al. (1998) argued against such a mechanism, 
because there was no significantly different histology between LPS from PTOS patients 
and normal individuals.  A light-microscope study of an LPS specimen from the proband 
in our family showed that the muscle fibers were displaced by fibrous and fatty tissues and 
scanty atrophic striated muscles remained.  This histological finding is consistent with 
dysgenesis of LPS.  Therefore, if ZFHX4 is relevant to congenital blepharoptosis, its 
abnormal expression might cause a failure of neuronal differentiation of the oculomotor 
nerve, leading to LPS dysgenesis. 
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In conclusion, we identified three possible regions candidate for PTOS1, 
8q21.11-q22.2, 12q24.32-qter and 14q21.1-q23.2, by a whole-genome linkage analysis.  
These regions do not definitely overlap with a 1p34.1-p32 segment to which PTOS1 was 
mapped (Engle et al. 1997), and one of the regions we assigned includes a segment 
containing ZFHX4 (McMullan et al. 2000).  Thus, our data may support the existence of 
the PTOS1 locus. It remains to be seen whether other PTOS1 families have mutations in 
ZFHX4, another gene, or in a putative ZFHX4 enhancer located at 8q21.11-q22.2. 
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Figure 1. Family tree with haplotypes at (A) 8q21.11-q22.2, (B) 12q24.32-qter and (C) 
14q21.1-q23.2 regions.  Closed, open and slash symbols indicate affected, unaffected, and 
deceased individuals, respectively. Double horizontal line depicts consanguineous marriage, 
and short bar above individual symbols indicate individuals examined clinically.  Thick 
columns depict disease-associated haplotypes.  
 
Figure 2. Blepharopotosis of two affected members (V-5 and III-5).  The proband (V-5) 
has unilateral blepharoptosis (A), and III-5 has bilateral ptosis (B).  Both patients have 
overaction of the frontalis muscle. 
 
Figure 3. Southern blot analysis of patients (P3) and a control individual (C) after digestion 
with three different enzymes, using probes for exons 2 and 12 of ZFHX4.  An extra band 
is seen in EcoRI fragments including ZFHX4 from a patient (III-5, P3) (A) and three 




Table.1 Polymerase chain reaction (PCR) primers for methylation-specific PCR and bisulfite sequencing 
 
 Primer           Sequences 5’→ 3’                          Anneal       Products 
temperature      size(bp) 
CpG1-MF    GTTTAGTCGTTCGGATCGCGTTCGT                    60              182 
CpG1-MR    AACTTAACCTCGAAACGCGCCAACG             
CpG1-UF     GTTAGGTTTAGTTGTTTGGATTGTGTTTGT             60              192 
CpG1-UR     TCCAAAACTTAACCTCAAAACACACCAACA     
CpG2-MF     GGGTTTTGTTTTTTTCGCGAGTTTC                   60              139 
CpG2-MR     TACGAAAAACCAATCATCCCAATCG              
CpG2-UF      TTTTTGGGTTTTGTTTTTTTTGTGAGTTTT             60              149 
CpG2-UR     ATAAATACAAAAAACCAATCATCCCAATCA         
Ex12-upF     GGAAAGTAAAGAAGTTGTTTTAAAA                  56              180 
Ex12-upR     ATAACAAAACAATACAACACAAATA  
Ex12-dwF     TGATAATGGTAGAAGGTAAAGTATT                   56              200   
Ex12-dwR    AACATATAAAACAAAAAAACCTCTA                                                    
 M methylated-specific, U unmethylated-specific, F forward primer, R reverse primer, up upstream restriction site,  
dw downstream restriction site 
Table.2 Log of odds (LOD) scores of candidate loci of the third hereditary congenital ptosis locus 
(PTOS1) 
                          Recombination Fraction (θ)              Multipoint 
 Locus        0.00        0.05        0.10        0.20        0.30        0.40      LOD score 
D8S551       0.95        1.12        1.16        1.01        0.68        0.29       1.46 
D8S525       0.15        0.12        0.09        0.05        0.02        0.00       1.51 
D8S270      -2.53       -1.33        -0.86        -0.36       -0.13       -0.02       1.39 
D8S1772      0.33        0.31        0.29        0.23        0.15        0.08       1.22 
D12S1679     -0.03       0.31        0.45        0.47        0.34        0.17       0.59 
D12S1659     0.15        0.12        0.09        0.05        0.02        0.00       1.39 
D12S97       -0.20       -0.11       -0.05        -0.00       0.00        0.00       1.61 
D12S1599     -0.78       -0.43       -0.27        -0.11       -0.04       -0.01       1.63 
D12S1723     0.15        0.25        0.27        0.23        0.14        0.06       1.79 
D14S1057     0.62        0.64        0.61        0.51        0.37        0.20      -1.00 
D14S276      0.46        0.65        0.72        0.65        0.44        0.19       1.31 
D14S66       -1.65       -1.15       -0.83        -0.45       -0.25       -0.12       2.01 
D14S274      -1.16       -0.30       -0.07        0.07        0.07        0.02       1.97 
D14S1038     -2.15       -1.64       -1.27        -0.76       -0.43       -0.19       1.94 
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